Table 2.
Characteristic | Reconstruction (n = 58) n (%) |
No reconstruction (n = 109) n (%) |
p Valuea |
---|---|---|---|
Age at diagnosis (years) | |||
Median (IQR) | 56 (44–63) | 66 (53–73) | <0.001 |
Race | |||
White | 12 (21) | 25 (33) | 0.056 |
Asian | 2 (3.4) | 19 (17) | |
Black | 34 (59) | 50 (46) | |
Hispanic | 7 (12) | 7 (6.4) | |
Other | 3 (5.2) | 8 (7.3) | |
Insurance | |||
Private | 34 (59) | 21 (19) | <0.001 |
Medicaid | 9 (16) | 35 (32) | |
Medicare | 15 (26) | 53 (49) | |
BMI | |||
Median (IQR) | 30 (26–35) | 28 (24–32) | 0.027 |
Charlson Comorbidity Index | |||
Median (IQR) | 1.00 (0.00–2.00) | 2.00 (1.00–4.00) | <0.001 |
Ever/former smoker | 18 (31) | 19 (17) | 0.052 |
MDC surgeon | 23 (40) | 34 (31) | 0.31 |
Surgeon gender | |||
Male | 25 (43) | 71 (65) | 0.008 |
Female | 33 (57) | 38 (35) | |
Type of surgery | |||
Unilateral mastectomy | 25 (43) | 94 (86) | <0.001 |
Bilateral mastectomy | 33 (57) | 15 (14) | |
Reconstruction type | |||
Autologous | 5 (8.6) | 0 (0) | <0.001 |
Implant | 53 (91) | 0 (0) | |
None | 0 (0) | 109 (100) |
IQR, interquartile range; BMI, body mass index; MDC, multidisciplinary breast clinic
aFisher’s exact test, Wilcoxon rank-sum test